프로그램

Time Title Chair/Speaker
08:55-09:05 Registration
09:05-09:06 Moderator Hye Ryoun Jang
Chair of Scientific Committee of CGTI
Samsung Medical Center
Sungkyunkwan University School of Medicine
09:06-09:09 Opening Remarks Yun Sil Chang
Director of Cell and Gene Therapy Institute(CGTI)
Samsung Medical Center(SMC)
Director of Samsung Advanced Institute for Health Sciences and Technology(SAIHST)
Sungkyunkwan University
09:09-09:12 Welcome Address WooSeong Huh
Executive Vice President
Chief Research Officer
Samsung Medical Center
09:12-09:15 Congratulatory Address Seung Woo Park
President & CEO of Samsung Medical Center
09:15-09:30 New Frontier for K-Gene Therapy: G-CROWN Platform Jeehun Lee
Samsung Medical Center
Sungkyunkwan University School of Medicine
09:30-09:35 Discussion
Session I. Translational & Clinical Research of Cell · Gene therapy for Incurable Diseases
Chair : Yun Sil Chang, Director of CGTI, SMC, Director of SAIHST, Sungkyunkwan University
Jeehun Lee, Samsung Medical Center, Sungkyunkwan University School of Medicine
09:35-09:55 MSC and MSC-EVs for the Treatment of Sepsis Claudia C. dos Santos
University of Toronto
Canada
09:55-10:00 Discussion
10:00-10:20 Personalized mRNA therapeutics for Targeting Neoantigens and Overexpressed Antigens in Children and Young Adults with high-risk brain tumours Bradley Thomas Sorenson
Providence Therapeutics Inc.
Canada
10:20-10:25 Discussion
10:25-10:45 Antisense Oligonucleotides (ASOs) for Rare Pediatric Neurological Disorders Olivia Kim-McManus
UC San Diego, USA
10:45-10:50 Discussion
10:50-11:00 Break
Session II. Advanced disease modeling for Aging and Longevity using Cell · Gene therapy
Chair : Byung-Ok Choi, Samsung Medical Center, Sungkyunkwan University School of Medicine
Jaewon Lee, Pusan National University/President of the Korean Society of Gerontology
11:00-11:15 Current trends and Future Directions of Aging Research;Diagnosis and Treatmemt of Aging Eun-Soo Kwon
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
11:15-11:30 Harnessing Stem Cells and Cellular Reprogramming Technologies for Treating Brain Disorders and Age-Related Diseases Jongpil Kim
Dongguk University
11:30-11:45 Therapeutic Approaches to Reverse Aging through Immune System Reprogramming Kyung A Cho
Chonnam National University
11:45-12:00 Discussion
12:00-13:00 Lunch
Session III. Special Lecture on Policy Act
Chair : Chang-Hwan Park, Korean Fund for Regenerative Medicine
Sung-Chul Jung, Ewha Womans University
13:00-13:20 From Clinical Research to Patient Treatment: The Evolving Role of Hospitals in Advancing Korea’s Regenerative Medicine Industry So Ra Park
President
Founder of Regenerative Medicine Acceleration Foundation (RMAF)
13:20-13:40 TBD Youngwoo Jeon
Yeouido St. Mary's Hospital
The Catholic University of Korea
13:40-14:00 Advanced Regenerative Medicine System: Policy Framework and Current Implementation Junmi Lee
Division of Regenerative Medicine Policy in the Ministry of Health and Welfare
14:00-14:15 Discussion
Session IV. Perspective: Advanced Technology of Cell · Gene therapy
Chair : Ji Hyeon Ju, Seoul St. Mary's Hospital, The Catholic University of Korea
Jae Young Lee, Samsung Medical Center, Sungkyunkwan University
14:15-14:30 In situ stemness assessment of human pluripotent stem cells through deep-learning-assisted holotomography Ki-Jun Yoon
Korea Advanced Institute of Science and Technology (KAIST)
14:30-14:45 Human Pluripotent Stem Cell-Derived Schwann Cells for Modeling and Therapeutic Development of Peripheral Nervous System Disorders Minseong Kim
Sejong University
14:45-15:00 Strategic selection of AAV capsids for human liver gene therapy Jaejun Kim
Sungkyunkwan University
15:00-15:15 Discussion
15:15-15:25 Break
Session V. Recent Advances and Future Perspectives I
Chair : Woong Sun, Korea University
Jong Wook Chang, Samsung Medical Center, Sungkyunkwan University
15:25-15:40 Electrochemical Metabolic Profiling for Label-Free, Non-Destructive Assessment of Living Cell State and Function Tae-Hyung Kim
Sungkyunkwan University
15:40-15:55 Human Periportal Liver Assembloids for in vitro Tissue Modeling Yohan Kim
Sungkyunkwan University
15:55-16:05 Discussion
Session VI. Recent Advances and Future Perspectives II
Chair : Oh Young Bang, Samsung Medical Center, Sungkyunkwan University School of Medicine
Jong Wook Hong, Hanyang University/President of Korean Society for Extracellular Vesicles (KSEV)
16:05-16:25 Engineered Extracellular Vesicles Enable Efficient Gene Editing in the CNS Samir EL Andaloussi
Karolinska Institutet/Karolinska University
Sweden
16:25-16:30 Discussion
16:30-16:45 Engineering Lipid Assemblies for Efficient Gene Delivery Hojun Kim
Korea Institute of Science and Technology (KIST)
16:45-16:50 Discussion
Session VII. Recent Advances and Future Perspectives III
Chair : Kyung-Mi Lee, Korea University
Hye Ryoun Jang, Samsung Medical Center, Sungkyunkwan University School of Medicine
16:50-17:05 Building Better CAR-NK Cells: Rational Strategies to Enhance Antitumor Function Duck Cho
Samsung Medical Center
17:05-17:20 Pathway-Level Demultiplexing of Driver Mutations Defines the Molecular Architecture of Pediatric Solid Tumors June-Young Koh
UC San Diego/Inocras Inc., USA
17:20-17:30 Discussion
17:30- Adjourn